Silvercrest Asset Management Group LLC Exagen Inc. Transaction History
Silvercrest Asset Management Group LLC
- $14.7 Billion
- Q3 2025
A detailed history of Silvercrest Asset Management Group LLC transactions in Exagen Inc. stock. As of the latest transaction made, Silvercrest Asset Management Group LLC holds 519,468 shares of XGN stock, worth $4.7 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
519,468
Previous 531,767
2.31%
Holding current value
$4.7 Million
Previous $3.71 Million
52.84%
% of portfolio
0.04%
Previous 0.03%
Shares
15 transactions
Others Institutions Holding XGN
# of Institutions
64Shares Held
8.96MCall Options Held
25.7KPut Options Held
0-
Rtw Investments, LP New York, NY1.7MShares$15.4 Million0.25% of portfolio
-
Vanguard Group Inc Valley Forge, PA734KShares$6.64 Million0.0% of portfolio
-
Balyasny Asset Management LLC Chicago, IL723KShares$6.55 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA675KShares$6.11 Million0.0% of portfolio
-
Kennedy Capital Management, Inc. St Louis, MO552KShares$4.99 Million0.15% of portfolio
About EXAGEN INC.
- Ticker XGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 16,260,400
- Market Cap $147M
- Description
- Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...